header
Image from OpenLibrary

Management of relapsed and refractory multiple myeloma / Samia Othman Abdelazeem ; Supervised Nasr Mohamed Ali Allahloubi , Mohamed Abdelmooti Samra , Raafat Mohamed Abdelfatah

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Samia Othman Abdelazeem , 2012Description: 222P. : charts , facsimiles ; 25cmOther title:
  • الجديد فى تشخيص وعلاج ارتجاع مرض الميلوما المتعددة [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical Summary: Relapsed MM. second ASCT , thalidomide , lenalidomide , bortecomib , Multiple myeloma is a plasma cell neoplasm that is characterized by anemia , skeletal destruction , hypercalcemia and renal failure . The disease is considered incurable , with a treatment course categorized by relapses and projected death within 5 years of diagnosis
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.M.Sc.2012.Sa.M (Browse shelf(Opens below)) Not for loan 01010110060392000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.M.Sc.2012.Sa.M (Browse shelf(Opens below)) 60392.CD Not for loan 01020110060392000

Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical

Relapsed MM. second ASCT , thalidomide , lenalidomide , bortecomib , Multiple myeloma is a plasma cell neoplasm that is characterized by anemia , skeletal destruction , hypercalcemia and renal failure . The disease is considered incurable , with a treatment course categorized by relapses and projected death within 5 years of diagnosis

Issued also as CD

There are no comments on this title.

to post a comment.